CBSTQ · Cannabist Co Holdings Inc.
Market Cap
$99,491
Shares
497.46M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$458.72M
-10.3%
FY2024
Net Income
-$105.89M
+39.7%
FY2024
Gross Margin
36.69%
+1.5pp
FY2024
Operating Margin
-4.86%
+15.7pp
FY2024
Diluted EPS
-$0.23
+47.7%
FY2024
Operating Cash Flow
-$23.38M
-412.9%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| $349.84M | $458.72M | $511.33M | $511.58M | $460.08M | $179.5M | |
| $246.59M | $290.43M | $331.36M | $310.16M | — | — | |
| $103.25M | $168.3M | $179.97M | $201.21M | $194.02M | $62.14M | |
| — | 36.69% | 35.2% | 39.33% | 42.17% | 34.62% | |
| $150.9M | $188.35M | $199.59M | $277.33M | $232.05M | $142.36M | |
| — | $11.4M | $18.61M | $44.53M | $26.08M | $3.64M | |
| $39.85M | $48.98M | $62.73M | $84.79M | $53M | $19.65M | |
| — | $190.57M | $285.21M | $617.45M | $304.38M | $142.36M | |
| -$49.94M | -$22.27M | -$105.24M | -$416.24M | -$110.37M | -$80.21M | |
| — | -4.86% | -20.58% | -81.36% | -23.99% | -44.69% | |
| -$10.09M | $26.71M | -$42.51M | -$331.45M | -$57.36M | -$60.56M | |
| -$76.15M | -$39.55M | -$63.66M | -$16.45M | -$36.35M | -$55.63M | |
| -$126.09M | -$61.82M | -$168.9M | -$432.69M | -$146.71M | -$135.85M | |
| $53.31M | $43.31M | $5.39M | -$11.21M | $139K | -$16.2M | |
| -$179.38M | -$105.89M | -$175.71M | -$416.01M | -$146.85M | -$119.65M | |
| — | -23.08% | -34.36% | -81.32% | -31.92% | -66.66% | |
| -$441K | $760K | $1.43M | -$5.48M | -$3.76M | -$23.86M | |
| — | -$105.89M | -$175.71M | -$416.01M | -$143.1M | -$95.79M | |
| USD/shares | -$0.38 | -$0.23 | -$0.44 | -$1.06 | -$0.42 | -$0.41 |
| USD/shares | -$0.38 | -$0.23 | -$0.44 | -$1.06 | -$0.42 | -$0.41 |
| shares | — | 462.5M | 402.78M | 392.57M | 338.75M | 232.58M |
| shares | — | 462.5M | 402.78M | 392.57M | 338.75M | 232.58M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Drug Manufacturers - Specialty & Generic median 2.10×
EV/EBIT
—
Drug Manufacturers - Specialty & Generic median 19.68×
P/E (TTM)
—
Drug Manufacturers - Specialty & Generic median 17.82×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Dispensary | $389,287,000 | $448,771,000 | $438,879,000 | $376,582,000 | $164,011,000 |
| Cultivation And Wholesale | $69,435,000 | $62,526,000 | $72,580,000 | $83,180,000 | $15,347,000 |
| Columbia Cares National Credit Card | $0 | $4,064,000 | $4,520,000 | $4,524,000 | — |
| Manufactured Product Other | $0 | $30,000 | $119,000 | $318,000 | $145,000 |
| Columbia Cares National Credit Card | — | $4,064,000 | $4,520,000 | $4,524,000 | — |
| Cultivation and Wholesale | — | $62,526,000 | $72,580,000 | $83,180,000 | — |
| Dispensary | — | $448,771,000 | $438,879,000 | $376,582,000 | — |